NLS Pharmaceutics Enhances CNS Research with AEX-6xx Drug Series Development NLS Pharmaceutics introduces the AEX-6xx series, enhancing its CNS research with novel compounds aimed at treating neurodegenerative disorders and cognition.

NLS Pharmaceutics Enhances CNS Research with AEX-6xx Drug Series Development #Switzerland #NLS_Pharmaceutics #Zurich #CNS_Therapy #Aexon_Labs